Skip to content
Toggle main navigation
Progeria Connect logo
Progeria Connect logo
  • Events
  • Groups
  • Request to join here
    Log in
    Select an available language
    EN

    News

    All
    Events
    Homepage News
    News
    Uncategorized

    Results (32)

    Progeria Research Foundation to Honor Gene-Editing Pioneer David R. Liu, Ph.D., and Peabody Philanthropists Cathy and Dave Gravel at 2026 Night of Wonder Gala

    Progeria Research Foundation to Honor Gene-Editing Pioneer David R. Liu, Ph.D., and Peabody Philanthropists Cathy and Dave Gravel at 2026 Night of Wonder Gala

    Base-editing innovator and longtime local supporters to receive PRF’s S.A.M. Award and Amy Award at biennial signature eventPEABODY, MA, Oct. 7, 2026 /PRNewswire – The Progeria Research Foundation (PRF) will honor gene-editing pioneer David R. Liu, Ph.D., and longtime supporters Cathy and David Gravel of GraVoc at its 2026 Night of Wonder Gala on Saturday, November 14 at the Westin Boston Seaport
    October 7, 2026
    Our 2026 Newsletter is here!

    Our 2026 Newsletter is here!

    2026 PRF NewsletterSeptember 2026 Newsletter pdfThe post Our 2026 Newsletter is here! appeared first on The Progeria Research Foundation.
    September 20, 2026
    The Okie Boys Jet Ski 1,300 Miles for Progeria Research

    The Okie Boys Jet Ski 1,300 Miles for Progeria Research

    The Okie Boys, a group of friends from Oklahoma, just rode jet skis 1,300 miles from Miami to Puerto Rico to raise money for progeria research. The trip started almost as a joke when Derek Hallaway decided to ride his jet skis to his home in Puerto Rico instead of shipping them, but it carried deep personal meaning: his younger brother died of progeria in 2006 at just three and a half years old. T
    July 16, 2026
    The Okie Boys Jet Ski 1,300 Miles for Progeria Research

    The Okie Boys Jet Ski 1,300 Miles for Progeria Research

    The Okie Boys, a group of friends from Oklahoma, just rode jet skis 1,300 miles from Miami to Puerto Rico to raise money for progeria research. The trip started almost as a joke when Derek Hallaway decided to ride his jet skis to his home in Puerto Rico instead of shipping them, but it carried deep personal meaning: his younger brother died of progeria in 2006 at just three and a half years old. T
    July 14, 2026
    The Progeria Research Foundation Celebrates 25 Years of Racing Toward a Cure

    The Progeria Research Foundation Celebrates 25 Years of Racing Toward a Cure

    25th Annual International Race for Research Set for September 19, 2026, in Peabody, MANEWS RELEASE: FOR IMMEDIATE RELEASEPEABODY, MA – The Progeria Research Foundation (PRF), an internationally-known nonprofit based in Peabody,will celebrate a landmark milestone this fall when it hosts its 25th Annual International Race for Research onSaturday, September 19, 2026. What began as a community 5k a qu
    July 1, 2026
    PRF’s 12th International Scientific Workshop

    PRF’s 12th International Scientific Workshop

    Maria Eriksson, Vicente Andrés, Mark W. Kieran & Leslie B. GordonPRF Scientific Workshop Summary Published in Nature Aging defines 6 strategic pillars for Progeria research!Two and a half days of groundbreaking science, powerful human connection, and renewed commitment to finding the cure.120PHYSICIANS, SCIENTISTS & ADVOCATES16COUNTRIES REPRESENTED50+SCIENTIFIC PRESENTATIONSIES6STRATEGICPRIORITIES
    July 1, 2026
    NEWS RELEASE: FOR IMMEDIATE RELEASE

    NEWS RELEASE: FOR IMMEDIATE RELEASE

    Sign Upfor OurUpdates! Sign Up Now Together, weWILLfind the cure! Donate Now The post NEWS RELEASE: FOR IMMEDIATE RELEASE appeared first on The Progeria Research Foundation.
    June 30, 2026
    PRF Announces Manufacturing Partnership with Forge Biologics to Advance Progeria Gene Therapy!

    PRF Announces Manufacturing Partnership with Forge Biologics to Advance Progeria Gene Therapy!

    PRF has entered into a manufacturing agreement with Forge Biologics to produce SamPro-2 – PRF’s investigational gene-editing therapy designed to correct the gene mutation that causes Progeria.This is a defining step toward Progeria gene therapy clinical trials.What is SamPro-2?SamPro-2 is PRF’s gene editing therapy designed to correct the single DNA letter misspelling that causes Progeria.DNA is t
    March 2, 2026
    Get PRF’s 2025 Newletter here!

    Get PRF’s 2025 Newletter here!

    Collaboration = ProgressThe Progerinin trial is a partnership between PRF, trial sponsor PRG Science & Technology (a Korean- based biotech company), Boston Children’s Hospital (the trial site), Brigham and Women’s Hospital (site for some trial tests), and of course the families who are with us every step of the way!Inside, you’ll get:Research Updates: Progerinin Clinical Trial is Well Underway! Ge
    September 25, 2025
    PRF’s Journey to the Cure Featured in New Yorker Magazine

    PRF’s Journey to the Cure Featured in New Yorker Magazine

    The Path to Cure Progeria is Here…After 6 years of intense work, culminating in the final design of the gene therapy drug that could cure Progeria, PRF’s pioneering Gene Editing program is ramping up its next stage of development: manufacturing the drug for human clinical trials.Base editing gene therapy uses CRISPR  technology to target a specific DNA base (or DNA letter) and change it to another
    August 8, 2025
    The 2024 Donor Impact Snapshot is here!

    The 2024 Donor Impact Snapshot is here!

    The post The 2024 Donor Impact Snapshot is here! appeared first on The Progeria Research Foundation.
    May 16, 2025
    New clinical trial with the drug Progerinin is officially underway

    New clinical trial with the drug Progerinin is officially underway

    PRF is thrilled to announce that the first Progerinin clinical trial patient visits are complete! Earlier this month, we welcomed US-residents Merlin (23) and Kaylee (21) to their week-long trial visits at Boston Children’s Hospital. This groundbreaking trial will explore whether Progerinin, combined with the life-extending drug lonafarnib (Zokinvy), is more effective than lonafarnib alone.  For m
    January 29, 2025
    Hot off the presses: PRF’s 2024 Newsletter!

    Hot off the presses: PRF’s 2024 Newsletter!

    So much progress, so much to share!! PRF’s 2024 newsletter is rife with exciting updates about our global work – supporting the most promising research toward better treatments and the CURE, and our strategic awareness efforts to find and help all children with Progeria around the world.Inside, you’ll get:the full scoop on the brand-new clinical trial we’re supporting to determine whether the addi
    October 30, 2024
    Mourning the loss of PRF Ambassador, Sammy Basso

    Mourning the loss of PRF Ambassador, Sammy Basso

    The Progeria Research Foundation is honoring the life of our Progeria researcher and PRF spokesperson, Sammy Basso. Sammy sadly passed away at the age of 28 on October 5, 2024.Sammy was the oldest known person living with classic Progeria, which gave him a unique perspective on life and an extraordinary drive to connect with others. He was known and adored throughout the world for his phenomenal o
    October 9, 2024
    BIG NEWS: Announcing the launch of a brand-new clinical drug trial!

    BIG NEWS: Announcing the launch of a brand-new clinical drug trial!

    BIG NEWS: Announcing the launch of a brand-new clinical drug trial!  We’re back at it! PRF is thrilled to announce the start of a new Progeria clinical trial with a new drug called Progerinin. PRF will help fund and coordinate this trial to determine whether a new drug, called Progerinin, plus the life-extending Progeria drug lonafarnib (Zokinvy) is more beneficial than lonaf
    September 30, 2024
    PRF now collaborating with Sentynl Therapeutics, new global owner of lonafarnib treatment (Zokinvy®)

    PRF now collaborating with Sentynl Therapeutics, new global owner of lonafarnib treatment (Zokinvy®)

    Effective Friday, May 3rd, 2024, Sentynl Therapeutics, Inc. (Sentynl), a U.S.-based biopharmaceutical company wholly-owned by Zydus Lifesciences, Ltd, has acquired global rights to lonafarnib (Zokinvy) from Eiger BioPharmaceuticals (Eiger). Zokinvy® is provided to families worldwide who are using the drug as a treatment for progeria.Based in San Diego, California, Sentynl is focused on providing n
    May 22, 2024
    PRF now collaborating with Sentynl Therapeutics, new global owner of lonafarnib treatment (Zokinvy©)

    PRF now collaborating with Sentynl Therapeutics, new global owner of lonafarnib treatment (Zokinvy©)

    Effective Friday, May 3rd, 2024, Sentynl Therapeutics, Inc. (Sentynl), a U.S.-based biopharmaceutical company wholly-owned by Zydus Lifesciences, Ltd, has acquired global rights to lonafarnib (Zokinvy) from Eiger BioPharmaceuticals (Eiger). Zokinvy® is provided to families worldwide who are using the drug as a treatment for progeria.Based in San Diego, California, Sentynl is focused on providing n
    May 4, 2024
    We did it – A decade of top Charity Navigator Ratings!

    We did it – A decade of top Charity Navigator Ratings!

    We’re thrilled to share that PRF has been awarded the highest 4-star Charity Navigator rating for our 9th straight year! Charity Navigator is the top evaluator of U.S.-based nonprofits, and this coveted 4-star rating is only awarded to 5% of the nonprofits evaluated. PRF earned this rating as a result of a proven track record in executing on our mission in a financially efficient way, as well as a
    January 5, 2024
    EXCITING NEWS – Sam Berns’ TEDx Talk Hits 100 Million Cross-Platform Views!

    EXCITING NEWS – Sam Berns’ TEDx Talk Hits 100 Million Cross-Platform Views!

    We are thrilled to announce that Sam Berns’ TEDx talk, ‘My Philosophy for a Happy Life,’ has now been viewed across TED and TEDx platforms more than 100 million times!Sam was the inspiration behind the creation of PRF.  He continues to inspire not only us in our mission to cure Progeria, but also the world with his words of wisdom. THANK YOU for helping to make this extraordinary milestone possibl
    October 15, 2023
    PRF Newsletter 2023

    PRF Newsletter 2023

    The word is out – PRF’s 2023 Newsletter is here! Thanks to your support, the news you’re about to read is chock full of exciting updates about PRF happenings all over the world, and details on our progress toward additional treatments and the CURE.Here are just a few highlights:A brand-new Progeria test was discovered that measures treatment benefit faster and reveals even longer lives with lonafa
    October 6, 2023
    Contact
    The Progeria Research Foundation
    P.O. Box 3453, Peabody, 01961

    Massachusetts

    USA

    PC@progeriaresearch.org
    (978) 535-2594
    Links
    • Privacy Policy
    • Terms of Use
    • About Sciensus
    • The Progeria Research Foundation
    Community engagement platform by Hivebrite.